FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Ambey Laboratories IPO and Mason Infratech IPO.
Ambey Laboratories IPO is a SME Book Built Issue IPO proposed to list at NSE SME while Mason Infratech IPO is a SME Book Built Issue proposed to list at NSE SME.
Ambey Laboratories IPO | Mason Infratech IPO | |
---|---|---|
Logo | ||
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | NSE SME | NSE SME |
Lead Managers | Fast Track Finsec Pvt Ltd | Expert Global Consultants Private Limited |
Registrar | Link Intime India Private Ltd | Kfin Technologies Limited |
Market Maker | Nikunj Stock Brokers Limited | Globalworth Securities Limited |
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Ambey Laboratories IPO is up to ₹44.68 Cr whereas the issue size of the Mason Infratech IPO is up to ₹30.46 Cr. The final issue price of Ambey Laboratories IPO is ₹68.00 per share and of Mason Infratech IPO is ₹64.00 per share.
Ambey Laboratories IPO | Mason Infratech IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹65.00 per share | ₹62.00 per share |
Issue Price (Upper) | ₹68.00 per share | ₹64.00 per share |
Issue Price (Final) | ₹68.00 per share | ₹64.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 2000 shares | 2000 shares |
Fresh Issue Size | 62,58,000 shares | 47,60,000 shares |
Fresh Issue Size (Amount) | up to ₹42.55 Cr | up to ₹30.46 Cr |
OFS Issue Size | 3,12,000 shares | |
OFS Issue Size (Amount) | up to ₹2.12 Cr | |
Issue Size Total | 65,70,000 shares | 47,60,000 shares |
Issue Size Total (Amount) | up to ₹44.68 Cr | up to ₹30.46 Cr |
Ambey Laboratories IPO opens on Jul 04, 2024, while Mason Infratech IPO opens on Jun 24, 2024. The closing date of Ambey Laboratories IPO and Mason Infratech IPO is Jul 08, 2024, and Jun 26, 2024, respectively.
Ambey Laboratories IPO | Mason Infratech IPO | |
---|---|---|
Anchor Bid Date | Jul 03, 2024 | Jun 21, 2024 |
Issue Open | Jul 04, 2024 | Jun 24, 2024 |
Issue Close | Jul 08, 2024 | Jun 26, 2024 |
Basis Of Allotment (Tentative) | Jul 09, 2024 | Jun 27, 2024 |
Initiation of Refunds (Tentative) | Jul 10, 2024 | Jun 28, 2024 |
Credit of Share (Tentative) | Jul 10, 2024 | Jun 28, 2024 |
Listing date (Tentative) | Jul 11, 2024 | Jul 01, 2024 |
Anchor Lockin End date 1 | Aug 08, 2024 | Jul 27, 2024 |
Anchor Lockin End date 2 | Oct 07, 2024 | Sep 25, 2024 |
Ambey Laboratories IPO P/E ratio is 27.81, as compared to Mason Infratech IPO P/E ratio of 24.33.
Ambey Laboratories IPO | Mason Infratech IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Ambey Laboratories Limited Financial Information (Restated)
|
Mason Infratech Limited Financial Information (Restated)Mason Infratech Limited's revenue increased by 112.76% and profit after tax (PAT) rose by 121.56% between the financial year ending with March 31, 2023 and March 31, 2022.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 94.97% | 98.20% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 69.90% | 71.60% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 27.81 | 24.33 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹171.64 Cr. | ₹112.46 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 20.80%% | 43.47%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 13.14%% | 30.98%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.58 | 0.94 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹2.44 | ₹2.63 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 20.80%% | 43.47%% |
In the Ambey Laboratories IPO retail investors (RII) are offered 21,84,000 shares while in Mason Infratech IPO retail investors are offered 21,84,000 shares. Qualified institutional buyers (QIB) are offered 12,52,000 shares in Ambey Laboratories IPO and 9,04,000 shares in Mason Infratech IPO.
Ambey Laboratories IPO | Mason Infratech IPO | |
---|---|---|
Anchor Investor Reserveration | 18,72,000 shares | 13,52,000 shares |
Market Maker Reserveration | 3,30,000 shares | 2,40,000 shares |
QIB | 12,52,000 shares | 9,04,000 shares |
NII | 6,06,001 shares | 6,80,000 shares |
RII | 21,84,000 shares | 15,84,000 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 40,42,001 shares | 31,68,000 shares |
Ambey Laboratories IPO subscribed 173.18x in total, whereas Mason Infratech IPO subscribed 32.89x.
Ambey Laboratories IPO | Mason Infratech IPO | |
---|---|---|
QIB (times) | 61.90x | 13.40x |
NII (times) | 324.22x | 50.20x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 195.06x | 36.59x |
Employee (times) | ||
Other (times) | ||
Total (times) | 173.18x | 32.89x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|